-
Mashup Score: 4Is combined exercise and incretin-based therapy the way forward for weight-loss maintenance? - 7 month(s) ago
Nature Reviews Endocrinology – Is combined exercise and incretin-based therapy the way forward for weight-loss maintenance?
Source: www.nature.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1 - Nature Reviews Endocrinology - 1 year(s) ago
This Review highlights the extrapancreatic actions of the incretin hormones gastric inhibitory polypeptide and glucagon-like peptide 1. These peptides are active on tissues with cardiometabolic relevance, such as liver, adipose tissue, muscle, the immune, kidney, heart, blood vessels and the central nervous system.
Source: NatureCategories: Endocrinology, Latest HeadlinesTweet-
In our latest issue: @RolaHammoud1 & @DanielJDrucker discuss the extrapancreatic actions of the #incretin hormones gastric inhibitory polypeptide and glucagon-like peptide 1 (£) https://t.co/sCGmhSgrmy https://t.co/EkYOHCz5r0
-
-
Mashup Score: 1How do the new obesity drugs work? - 1 year(s) ago
Drugs like Wegovy and Ozempic are growing in popularity as obesity medications. This STAT explainer video shows how they work in the body.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
Watch: How do the new #obesity drugs work? https://t.co/hRJSmebVET via @statnews #glp1 #incretin #semaglutide #wegovy #Ozempic #weightloss
-
-
Mashup Score: 0Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes - 2 year(s) ago
The fact that stimulation of insulin is much greater after an oral or enteral rather than isoglycaemic intravenous administration of glucose has been known for more than 60 years—this incretin effect is mediated by two gut hormones—GLP-1 and GIP. Management of people with type 2 diabetes and obesity is being revolutionised with the emergence of increasingly effective therapies based on GLP-1.1…
Categories: Endocrinology, Latest HeadlinesTweet-
Isseki nichō (one stone, two birds): a dual #incretin receptor agonist for type 2 #diabetes https://t.co/53Rxgpocd0 #T2D #tirzepatide #Japan https://t.co/kPVh9XhTvP
-
-
Mashup Score: 1Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes - 2 year(s) ago
The fact that stimulation of insulin is much greater after an oral or enteral rather than isoglycaemic intravenous administration of glucose has been known for more than 60 years—this incretin effect is mediated by two gut hormones—GLP-1 and GIP. Management of people with type 2 diabetes and obesity is being revolutionised with the emergence of increasingly effective therapies based on GLP-1.1…
Categories: Endocrinology, Latest HeadlinesTweet-
Michael Horowitz & colleagues comment: Isseki nichō (one stone, two birds): a dual #incretin receptor agonist for type 2 #diabetes https://t.co/53Rxgpocd0 #tirzepatide #Japan #T2D https://t.co/yF51pWBw74
-
-
Mashup Score: 1Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes - 2 year(s) ago
The fact that stimulation of insulin is much greater after an oral or enteral rather than isoglycaemic intravenous administration of glucose has been known for more than 60 years—this incretin effect is mediated by two gut hormones—GLP-1 and GIP. Management of people with type 2 diabetes and obesity is being revolutionised with the emergence of increasingly effective therapies based on GLP-1.1…
Categories: Endocrinology, Latest HeadlinesTweet-
Michael Horowitz & colleagues comment on: Isseki nichō (one stone, two birds): a dual #incretin receptor agonist for type 2 #diabetes https://t.co/53Rxgpocd0 #T2D #tirzepatide https://t.co/1kUcXXA9Px
-
-
Mashup Score: 1Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes - 2 year(s) ago
The fact that stimulation of insulin is much greater after an oral or enteral rather than isoglycaemic intravenous administration of glucose has been known for more than 60 years—this incretin effect is mediated by two gut hormones—GLP-1 and GIP. Management of people with type 2 diabetes and obesity is being revolutionised with the emergence of increasingly effective therapies based on GLP-1.1…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read the Linked Comment: Isseki nichō (one stone, two birds): a dual #incretin receptor agonist for type 2 #diabetes https://t.co/53Rxgpocd0 #T2D #tirzepatide https://t.co/9Bg95Zfsxu
-
-
Mashup Score: 0Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes - 2 year(s) ago
The fact that stimulation of insulin is much greater after an oral or enteral rather than isoglycaemic intravenous administration of glucose has been known for more than 60 years—this incretin effect is mediated by two gut hormones—GLP-1 and GIP. Management of people with type 2 diabetes and obesity is being revolutionised with the emergence of increasingly effective therapies based on GLP-1.1…
Categories: Endocrinology, Latest HeadlinesTweet-
Online—Isseki nichō (one stone, two birds): a dual #incretin receptor agonist for type 2 #diabetes https://t.co/53Rxgpocd0 #T2D #tirzepatide https://t.co/DRIjqqzV4U
-
-
Mashup Score: 2Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes - 2 year(s) ago
The fact that stimulation of insulin is much greater after an oral or enteral rather than isoglycaemic intravenous administration of glucose has been known for more than 60 years—this incretin effect is mediated by two gut hormones—GLP-1 and GIP. Management of people with type 2 diabetes and obesity is being revolutionised with the emergence of increasingly effective therapies based on GLP-1.1…
Categories: Endocrinology, Latest HeadlinesTweet-
Isseki nichō (one stone, two birds): a dual #incretin receptor agonist for type 2 #diabetes https://t.co/53Rxgpocd0 #T2D #tirzepatide https://t.co/oiwzHYe6fM
-
-
Mashup Score: 1Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes - 2 year(s) ago
The fact that stimulation of insulin is much greater after an oral or enteral rather than isoglycaemic intravenous administration of glucose has been known for more than 60 years—this incretin effect is mediated by two gut hormones—GLP-1 and GIP. Management of people with type 2 diabetes and obesity is being revolutionised with the emergence of increasingly effective therapies based on GLP-1.1…
Categories: Endocrinology, Latest HeadlinesTweet-
Online—Isseki nichō (one stone, two birds): a dual #incretin receptor agonist for type 2 #diabetes https://t.co/53Rxgpocd0 #T2D #tirzepatide #Japan https://t.co/YIu6sE8pbb
-
From our October issue: a Journal Club by Julie Abildgaard discusses a paper looking at the combined effects of #exercise and #incretin-based therapy (£) https://t.co/P0ev6ikP3C https://t.co/9MpuQqCGex